Research

2003

Principal Investigator: Levetiracetam (N-type calcium channel
blocker) in the treatment of social phobia: UCB Pharma grant.

2000

Co-Investigator: Fluoxetine and Olanzapine in the treatment of
treatment-resistant depression: Lilly grant.

2000

Co-Investigator: Sigma opioid receptor agonist in the treatment of
depression: Otsuka grant.

1998

Principal Investigator: Substance P Antagonist in the
treatment of social phobia: Novartis grant.

1997

Co-Investigator: Lamotrigine in the treatment of bipolar
depression: Glaxo Wellcome grant.

1993

Principal Investigator: Brofaromine (Reversible MAO B Inhibitor)
in the treatment of social phobia. Ciba-Geigy grant.